DE602006015968D1 - Zubereitungen von pro-insulin-c-peptid mit verzögerter freisetzung - Google Patents

Zubereitungen von pro-insulin-c-peptid mit verzögerter freisetzung

Info

Publication number
DE602006015968D1
DE602006015968D1 DE602006015968T DE602006015968T DE602006015968D1 DE 602006015968 D1 DE602006015968 D1 DE 602006015968D1 DE 602006015968 T DE602006015968 T DE 602006015968T DE 602006015968 T DE602006015968 T DE 602006015968T DE 602006015968 D1 DE602006015968 D1 DE 602006015968D1
Authority
DE
Germany
Prior art keywords
composition
peptide
gel
insulin
preparations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006015968T
Other languages
English (en)
Inventor
John Wahren
Anders Carlsson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cebix Inc
Original Assignee
Cebix Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cebix Inc filed Critical Cebix Inc
Publication of DE602006015968D1 publication Critical patent/DE602006015968D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
DE602006015968T 2005-06-02 2006-06-02 Zubereitungen von pro-insulin-c-peptid mit verzögerter freisetzung Active DE602006015968D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0511269.3A GB0511269D0 (en) 2005-06-02 2005-06-02 Sustained release preparation of pro-insulin C-peptide
PCT/GB2006/001997 WO2006129095A2 (en) 2005-06-02 2006-06-02 Sustained release preparations of pro-insulin c-peptide

Publications (1)

Publication Number Publication Date
DE602006015968D1 true DE602006015968D1 (de) 2010-09-16

Family

ID=34835031

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006015968T Active DE602006015968D1 (de) 2005-06-02 2006-06-02 Zubereitungen von pro-insulin-c-peptid mit verzögerter freisetzung

Country Status (6)

Country Link
US (1) US8927489B2 (de)
EP (1) EP1912669B1 (de)
AT (1) ATE476195T1 (de)
DE (1) DE602006015968D1 (de)
GB (1) GB0511269D0 (de)
WO (1) WO2006129095A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0511269D0 (en) 2005-06-02 2005-07-13 Creative Peptides Sweden Ab Sustained release preparation of pro-insulin C-peptide
WO2008118387A2 (en) * 2007-03-23 2008-10-02 Wayne State University Erythrocyte atp-release modulators
WO2008118390A2 (en) * 2007-03-23 2008-10-02 Wayne State University Biomarkers for diagnostic and therapeutic methods
WO2011081915A2 (en) * 2009-12-15 2011-07-07 Cebix Inc. Methods for treating erectile dysfunction in patients with insulin-dependent diabetes
KR20130115086A (ko) 2010-05-17 2013-10-21 세빅스 인코포레이티드 페길화된 c-펩티드
AU2012214283B2 (en) 2011-02-11 2016-01-28 The Regents Of The University Of Michigan Tripeptide compositions and methods for treatment of diabetes

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2143590A (en) * 1936-09-26 1939-01-10 Univ Alberta Insulin preparation and process of producing crystals of insulin
US2882203A (en) * 1951-06-26 1959-04-14 Novo Terapeutisk Labor As Injectable insulin preparation with protracted effect
NL289055A (de) * 1963-02-15
US3852422A (en) * 1971-06-26 1974-12-03 Serono Ist Farm Long-active gonadotropins
BE795516A (fr) * 1972-02-17 1973-08-16 Ciba Geigy Preparations de peptides huileuses et injectables et procede pour leur preparation
CA1176158A (en) 1981-08-27 1984-10-16 Ronald E. Chance Pharmaceutical formulations comprising human insulin and human c-peptide
KR890002631B1 (ko) 1984-10-04 1989-07-21 몬산토 캄파니 생물학적으로 활성인 소마토트로핀을 지속적으로 유리하는 조성물
GB9108634D0 (en) 1991-04-23 1991-06-12 Ciba Geigy Pharmaceutical compositions
HU225496B1 (en) 1993-04-07 2007-01-29 Scios Inc Pharmaceutical compositions of prolonged delivery, containing peptides
US5595760A (en) * 1994-09-02 1997-01-21 Delab Sustained release of peptides from pharmaceutical compositions
DE69529998D1 (de) 1994-12-23 2003-04-24 Novo Nordisk As Glp-1 zusammensetzungen mit verlängerter wirkdauer
JPH10511340A (ja) 1995-02-09 1998-11-04 ブリガム アンド ウィメンズ ホスピタル ゲル生成ポリペプチド誘導体
US20010007673A1 (en) * 1999-11-12 2001-07-12 Merrill Seymour Goldenberg Sustained-release delayed gels
FR2776520B1 (fr) * 1998-03-25 2000-05-05 Sod Conseils Rech Applic Nouvelles compositions pharmaceutiques destinees a la liberation prolongee de peptides et leur procede de preparation
DE10041478A1 (de) * 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung
DE10055857A1 (de) * 2000-11-10 2002-08-22 Creative Peptides Sweden Ab Dj Neue pharmazeutische Depotformulierung
GB0117057D0 (en) 2001-07-12 2001-09-05 Ferring Bv Pharmaceutical composition
US7098305B2 (en) * 2001-09-06 2006-08-29 Ardana Bioscience Limited Sustained release of microcrystalline peptide suspensions
BR0308137A (pt) 2002-03-04 2005-01-04 Sod Conseils Rech Applic Formulações de droga de liberação constante contendo um peptìdeo veìculo
GB0218970D0 (en) 2002-08-14 2002-09-25 Creative Peptides Sweden Ab Fragments of Insulin c-peptide
US7884185B2 (en) * 2004-07-28 2011-02-08 University Of Delaware Hydrogels and uses thereof
US20060046962A1 (en) * 2004-08-25 2006-03-02 Aegis Therapeutics Llc Absorption enhancers for drug administration
GB0511269D0 (en) 2005-06-02 2005-07-13 Creative Peptides Sweden Ab Sustained release preparation of pro-insulin C-peptide
KR20130115086A (ko) * 2010-05-17 2013-10-21 세빅스 인코포레이티드 페길화된 c-펩티드

Also Published As

Publication number Publication date
EP1912669A2 (de) 2008-04-23
US8927489B2 (en) 2015-01-06
EP1912669B1 (de) 2010-08-04
WO2006129095A2 (en) 2006-12-07
ATE476195T1 (de) 2010-08-15
WO2006129095A3 (en) 2007-05-10
GB0511269D0 (en) 2005-07-13
US20090170761A1 (en) 2009-07-02

Similar Documents

Publication Publication Date Title
MY143795A (en) Tetrahydropyridoindole derivatives
TNSN05254A1 (en) Derivatives of 2-acylamino-4-phenylthiazole, preparation method thereof and application of same in therapeutics
TW200716631A (en) Pyrido[2,3-d]pyrimidines useful as HCV inhibitors, and methods for the preparation thereof
TW200727903A (en) Stable pharmaceutical compositions of 5, 10 methylenetetrahydrofolate
ATE470443T1 (de) Indol-1-yl-essigsäurederivate
MX2010006370A (es) Composiciones de activo antitranspirante que tienen un cromatograma sec que exhibe una intensidad de pico 4 sec elevada.
MY144992A (en) Substituted 1,2,3,4-tetrahydroisoquinoline derivatives.
EP1670450B8 (de) Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa
WO2007076085A3 (en) Fused pyrimidones and thiopyrimidones, and uses thereof
CO5660287A2 (es) Derivados de tetrahidrocarbazol y su uso farmaceutico
EA200702589A1 (ru) 2,6-хинолинильные производные, способы их получения и их применение
DE602006015968D1 (de) Zubereitungen von pro-insulin-c-peptid mit verzögerter freisetzung
EA200701172A1 (ru) 2-алкокси-3,4,5-тригидроксиалкиламиды, их получение, композиции, их содержащие, и применение
WO2007092343A3 (en) Novel epoprostenol formulation and method of making thereof
BRPI0606974A2 (pt) uso de compostos de complexo de ferro(iii)
TW200613279A (en) New pesticides
IL165217A0 (en) Pesticidal pyridinecarboxamide derivatives
SE0301320D0 (sv) Positive modulators of nicotinic acetylcholine receptors
WO2006105482A3 (en) Controlled release pharmaceutical compositions of liothyronine and methods of making and using the same
ATE548043T1 (de) Polymorphe von 3-o-(3',3'- dimethylsuccinyl)betulinsäure-di-n-methyl-d- glucamin
TW200640858A (en) Substituted pyrroles, compositions containing them, method of manufacture and use
BRPI0507811A (pt) derivados de 7h-pirrolopirimidina
SE0300457D0 (sv) Novel compounds
NO20082848L (no) Farmasoytisk formulering for behandling av osteoartritt inneholdende klodronsyre og hyaluronsyre
ATE412404T1 (de) Stabile orale pharmazeutische zusammensetzungen von buprenorphin und salz davon